Fingerprint
Dive into the research topics of 'Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands
Bart Slob*, Tanja Fens, Maaike Weersma, Maarten Postma, Cornelis Boersma, Lisa de Jong
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
18
Downloads
(Pure)